Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome (Q34950855)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome |
scientific article |
Statements
1 reference
Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome (English)
1 reference
Catherine Skagen
1 reference
Michael Einstein
1 reference
Michael R Lucey
1 reference
Adnan Said
1 reference
1 August 2009
1 reference
1 reference
Identifiers
1 reference